Journal Watch · Nature Reviews Molecular Cell Biology · 2026

Inflammageing and clonal haematopoiesis interplay and their impact on human disease.

In this Review, we discuss the molecular and cellular mechanisms that cause CHIP, its interplay with inflammageing, as well as the pathophysiological consequences and the translational implications for diseases that affect older individuals.

Hajishengallis G, Chavakis TNature Reviews Molecular Cell Biology3 min readPharma relevance 30/100

DOI: 10.1038/s41580-025-00936-yPMID: 41491423Study type: review / perspective

TL;DR

In this Review, we discuss the molecular and cellular mechanisms that cause CHIP, its interplay with inflammageing, as well as the pathophysiological consequences and the translational implications for diseases that affect older individuals.

Key findings

  • A recent surge of discoveries has increased our understanding of the CHIP-inflammageing interplay, from a mechanistic and clinical perspective, highlighting its broader relevance to age-related diseases.
  • In this Review, we discuss the molecular and cellular mechanisms that cause CHIP, its interplay with inflammageing, as well as the pathophysiological consequences and the translational implications for diseases that affect older individuals.

What they did

Inflammageing, in turn, promotes functional impairment of normal HSCs, including reduced self-renewal potential. By contrast, CHIP-mutant HSCs not only are resistant to inflammageing-induced functional decline but also gain a selective expansion advantage in an inflammatory environment.

Full abstract (original)

Background: Clonal haematopoiesis of indeterminate potential (CHIP) is an ageing-related condition associated with a substantial fraction of circulating leukocytes having descended from a single somatically mutated haematopoietic stem cell (HSC). CHIP increases the risk of haematological malignancies and several chronic diseases (for example, cardiovascular pathologies) and contributes to persistent, low-grade inflammation or inflammageing.

What they did: Inflammageing, in turn, promotes functional impairment of normal HSCs, including reduced self-renewal potential. By contrast, CHIP-mutant HSCs not only are resistant to inflammageing-induced functional decline but also gain a selective expansion advantage in an inflammatory environment.

Results & conclusions: A recent surge of discoveries has increased our understanding of the CHIP-inflammageing interplay, from a mechanistic and clinical perspective, highlighting its broader relevance to age-related diseases. In this Review, we discuss the molecular and cellular mechanisms that cause CHIP, its interplay with inflammageing, as well as the pathophysiological consequences and the translational implications for diseases that affect older individuals.

Abstract © the authors / Nature Reviews Molecular Cell Biology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41580-025-00936-y · PubMed 41491423.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Nature Reviews Molecular Cell Biology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Reviews Molecular Cell Biology study find?

In this Review, we discuss the molecular and cellular mechanisms that cause CHIP, its interplay with inflammageing, as well as the pathophysiological consequences and the translational implications for diseases that affect older individuals.

What type of study is this?

It is a review / perspective, published in Nature Reviews Molecular Cell Biology in 2026. Inflammageing, in turn, promotes functional impairment of normal HSCs, including reduced self-renewal potential.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41580-025-00936-y. PubMed ID: 41491423. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Hajishengallis G, Chavakis T. Inflammageing and clonal haematopoiesis interplay and their impact on human disease.. Nature Reviews Molecular Cell Biology (2026). DOI: 10.1038/s41580-025-00936-y.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/inflammageing-and-clonal-haematopoiesis-interplay-and-their-impact-on-hu-00936y/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides